Furthermore, it was linked to classic tumor-related pathways, including KRAS, PI3K-AKT-mTOR, and MYC, as well as cell cycle and DNA repair pathways, such as the G2M checkpoint and E2F targets. This evidence concerns the gene KRAS and neoplasm.